Conversely, the inhibition of ERα expression may result in the upregulation of peroxisome proliferator-activated receptor gamma (PPARγ), which, in turn, may lead to the inhibition of proliferation in endometrial cancer cells [213]. The gene discussed is ESR1; the disease is endometrial cancer.